...AI Inc. Pontin served as senior adviser and senior partner at Flagship Pioneering. Rare disease and oncology play SpringWorks Therapeutics Inc. (NASDAQ:SWTX...
...Robert Kiss from VP to SVP of process and analytical development. Gunjan Ohri DCVC Bio Section 32 AlloVir Inc. Illumina Inc. SpringWorks Therapeutics Inc. NeoGenomics...

...creation of an externalization model for stalled programs. She was the founder and president of SpringWorks Therapeutics Inc....

...he’s watching two other targeted oncology companies. SpringWorks Therapeutics Inc....

...company Iovance Biotherapeutics Inc. (NASDAQ:IOVA) hired Jean-Marc Bellemin as CFO. He was EVP and CFO at Gritstone Oncology Inc. (NASDAQ:GRTS).SpringWorks Therapeutics Inc. (NASDAQ:SWTX...
...NALP3; CIAS1) – NLR family pyrin domain containing 3 Danielle Golovin Sarepta Therapeutics Inc. Iovance Biotherapeutics Inc. Gritstone Oncology Inc. SpringWorks Therapeutics Inc. NodThera...

...setbacks for the oncology company. Shares of Spectrum fell 11% to $3.40.Jazz takes rights to SpringWorks’...
...inhibitor program including PF-04457845 from SpringWorks Therapeutics Inc. (NASDAQ:SWTX), and plans to develop the therapy for post-traumatic stress disorder. SpringWorks...
...withdrawal and fear extinction. Jazz will also assume obligations owed to Pfizer Inc. (NYSE:PFE), which spun out SpringWorks...

...Inc. (NASDAQ:BLUE), Surface Oncology Inc. (NASDAQ:SURF), Blueprint Medicines Corp. (NASDAQ:BPMC), Translate Bio Inc. (NASDAQ:TBIO) and SpringWorks Therapeutics Inc....

...Bio Inc. (NASDAQ: VIE), which spun out of AstraZeneca plc (LSE:AZN; NYSE:AZN) in 2018, and SpringWorks Therapeutics Inc....
...following its $172.6 million IPO in October, with a current valuation of about $1.5 billion. SpringWorks...
...later, this September, brought in $186.3 million in an IPO, at a $778.2 million valuation. SpringWorks...

...γ secretase to inhibit NOTCH signaling are in the clinic. The most advanced, nirogacestat from SpringWorks Therapeutics Inc....

...John Flavin, who will remain as an independent director. Sullivan was founder and president of SpringWorks Therapeutics Inc....

...NASDAQ:STSA) 09/12/19 $82.5 $249.1 $249.2 0% 10x Genomics Inc. (NASDAQ:TXG) 09/12/19 $448.5 $3,718.6 $4,805.6 29% SpringWorks Therapeutics Inc....